Your browser doesn't support javascript.
loading
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines.
Koskinas, Konstantinos C; Gencer, Baris; Nanchen, David; Branca, Mattia; Carballo, David; Klingenberg, Roland; Blum, Manuel R; Carballo, Sebastian; Muller, Olivier; Matter, Christian M; Lüscher, Thomas F; Rodondi, Nicolas; Heg, Dik; Wilhelm, Matthias; Räber, Lorenz; Mach, François; Windecker, Stephan.
Afiliação
  • Koskinas KC; Department of Cardiology, University Hospital Bern, Switzerland.
  • Gencer B; Division of Cardiology, Geneva University Hospital, Switzerland.
  • Nanchen D; Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland.
  • Branca M; Clinical Trials Unit Bern, University of Bern, Switzerland.
  • Carballo D; Division of Cardiology, Geneva University Hospital, Switzerland.
  • Klingenberg R; Department of Cardiology, University Hospital Zurich, Switzerland.
  • Blum MR; Department of General Internal Medicine, Bern University Hospital, Switzerland.
  • Carballo S; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland.
  • Muller O; Service of Internal Medicine, Geneva University Hospital, Switzerland.
  • Matter CM; Service of Cardiology, Lausanne University Hospital, Switzerland.
  • Lüscher TF; Department of Cardiology, University Hospital Zurich, Switzerland.
  • Rodondi N; Royal Brompton and Harefield Hospital Trust and Imperial College, UK.
  • Heg D; Department of General Internal Medicine, Bern University Hospital, Switzerland.
  • Wilhelm M; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland.
  • Räber L; Clinical Trials Unit Bern, University of Bern, Switzerland.
  • Mach F; Department of Cardiology, University Hospital Bern, Switzerland.
  • Windecker S; Department of Cardiology, University Hospital Bern, Switzerland.
Eur J Prev Cardiol ; 28(1): 59-65, 2021 03 23.
Article em En | MEDLINE | ID: mdl-33755142
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiologia / Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose / Inibidores de PCSK9 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Eur J Prev Cardiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiologia / Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose / Inibidores de PCSK9 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Eur J Prev Cardiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido